HOOD vs IMDX · P/E 48, rev $2.38B vs rev $271.0K
Robinhood Markets Inc (HOOD) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vladimir Tenev.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported HOOD revenue for 2026-06-30 was $2.38B. Net income was $911.0M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
HOOD currently screens at market cap $88.36B and trailing P/E 47.6. IMDX currently screens at market cap $0.
Not investment advice. Open the HOOD and IMDX stock pages for the full models.
Not investment advice.